Point72 Hong Kong LTD Avrobio, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $1,677 - $2,973	-2,236 Reduced 69.68%	973 $1,000
Q1 2022 May 16, 2022	BUY	$1.29 - $4.04 $291 - $913	226 Added 7.58%	3,209 $4,000
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $5,523 - $9,686	-1,601 Reduced 34.93%	2,983 $11,000
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $25,349 - $42,539	4,584 New	4,584 $26,000
Q1 2020 May 15, 2020	SELL	$10.08 - $27.21 $12,781 - $34,502	-1,268 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $16,547 - $27,743	1,268 New	1,268 $26,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.